Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations

Overview of attention for article published in Neurology and Therapy, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#36 of 552)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
twitter: 2 X users

patent: 3 patents
video: 1 YouTube creator

Citations

dimensions_citation: 99 Dimensions

Readers on

mendeley: 101 Mendeley

Summary News Blogs X Patents YouTube Dimensions citations

So far, Altmetric has seen 1 blog post.

Switching from Fingo

Multiple Sclerosis Research, 05 Aug 2022

You asked about switching from fingolimod to another imod or anti-CD20. I am sorry I can’t give advice and maybe profK can tell…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.